NCT00884910View on ClinicalTrials.gov

Long Term Use of the Provox Vega 22.5

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Total Laryngectomy
Interventions
DEVICE

Provox Vega voice prosthesis 22.5 Fr

The patients' current Provox2 voice prosthesis will be removed and the new Provox Vega voice prosthesis will be inserted.

Trial Locations (1)

1066 CX

Netherlands Cancer Institute, Amsterdam

Sponsors

Lead Sponsor

Atos Medical AB
All Listed Sponsors
collaborator

The Netherlands Cancer Institute

OTHER

lead

Atos Medical AB

INDUSTRY

NCT00884910 - Long Term Use of the Provox Vega 22.5 | Biotech Hunter | Biotech Hunter